Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wolfgang Hassfeld"'
Publikováno v:
Scandinavian Journal of Rheumatology. 29:73-84
It is very difficult to predict future treatment modalities especially in diseases like rheumatoid arthritis (RA) with unknown etiology and pathogenesis. In the near future, traditional disease-modifying antirheumatic drugs (DMARD) alone, in combinat
Autor:
Günter Steiner, Karl Skriner, Wolfgang Hassfeld, Peter Petera, Josef S. Smolen, Christof Zimmermann
Publikováno v:
Arthritis & Rheumatism. 41:1938-1945
Objective The characteristics of 3 patients with longstanding rheumatoid arthritis (RA) and consecutive evolution of limited cutaneous systemic sclerosis (lcSSc) were evaluated and compared with those of patients with lcSSc alone (n = 20) or with RA
Autor:
Wolfgang Hassfeld, Andrea Studnicka-Benke, Josef S. Smolen, Karl Skriner, Winfried Graninger, Günter Steiner, Inge Fischer
Publikováno v:
Arthritis & Rheumatism. 38:777-785
Objective. To assess the significance of autoantibodies to RA33, the A2 protein of the heterogeneous nuclear ribonucleoproteins (hnRNP), and to the related hnRNP proteins A1, B1, and B2 in rheumatic diseases. Methods. Using a partially purified prepa
Autor:
Günter Steiner, David A. Mathison, Wolfgang Hassfeld, Eng M. Tan, Douglas S. Portman, Edward K. L. Chan, Gideon Dreyfuss
Serum from a patient showing symptoms related to autoimmunity was found to contain autoantibodies to the nuclear mitotic apparatus (NuMA) protein and to several novel nuclear antigens with estimated molecular weights of 40, 43, 72, 74 and 82 kDa. Usi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e7a71f2fa1ba7fd0792a90bb579f04c
https://europepmc.org/articles/PMC147279/
https://europepmc.org/articles/PMC147279/
Autor:
Wolfgang Hassfeld, O. Scherak, Norbert Thumb, Klaus Hartmuth, Josef S. Smolen, Günter Steiner, Gernot Kolarz, Winfried Graninger
Publikováno v:
Arthritis & Rheumatism. 32:1515-1520
Using immunoblot analysis with soluble nuclear extracts from HeLa cells, we identified autoantibodies to an antigen with a molecular weight of approximately 33,000 in 36% of 95 sera from rheumatoid arthritis patients, but in only 1 of 170 controls. T